ProfileGDS4718 / 209218_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 93% 69% 70% 93% 94% 97% 97% 90% 83% 95% 95% 89% 98% 98% 91% 97% 90% 98% 93% 86% 96% 95% 95% 94% 96% 98% 89% 95% 90% 98% 96% 96% 84% 93% 97% 92% 97% 91% 77% 75% 85% 99% 94% 98% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.8925193
GSM549102patient 115, normal, homogenized [OPG study]6.7426869
GSM549104patient 119, normal, homogenized [OPG study]6.931970
GSM549108patient 138, normal, homogenized [OPG study]9.778293
GSM549119patient 077, normal, homogenized [OPG study]10.026194
GSM549133patient 032, cancer, homogenized [OPG study]10.831297
GSM549139patient 042, cancer, homogenized [OPG study]10.972197
GSM549099patient 107, normal, homogenized [OPG study]9.0827390
GSM549109patient 139, normal, homogenized [OPG study]8.1503983
GSM549110patient 046, normal, homogenized [OPG study]10.37695
GSM549114patient 063, normal, homogenized [OPG study]10.344695
GSM549122patient 082, normal, homogenized [OPG study]9.1270689
GSM549134patient 033, cancer, homogenized [OPG study]11.507198
GSM549136patient 036, cancer, homogenized [OPG study]11.671398
GSM549140patient 044, cancer, homogenized [OPG study]9.3914691
GSM549111patient 047, normal, homogenized [OPG study]11.067497
GSM549113patient 057, normal, homogenized [OPG study]9.306690
GSM549132patient 031, cancer, homogenized [OPG study]11.296998
GSM549137patient 038, cancer, homogenized [OPG study]9.6810293
GSM549142patient 047, cancer, homogenized [OPG study]8.2161886
GSM549100patient 110, normal, homogenized [OPG study]10.618596
GSM549107patient 135, normal, homogenized [OPG study]10.489795
GSM549115patient 068, normal, homogenized [OPG study]10.565995
GSM549116patient 072, normal, homogenized [OPG study]10.02594
GSM549120patient 078, normal, homogenized [OPG study]10.618796
GSM549131patient 030, cancer, homogenized [OPG study]11.335398
GSM549118patient 074, normal, homogenized [OPG study]9.1209289
GSM549129patient 027, cancer, homogenized [OPG study]10.050695
GSM549123patient 088, normal, homogenized [OPG study]9.1713690
GSM549124patient 006, cancer, homogenized [OPG study]11.147398
GSM549126patient 015, cancer, homogenized [OPG study]10.373696
GSM549128patient 025, cancer, homogenized [OPG study]10.471496
GSM549103patient 117, normal, homogenized [OPG study]8.2309784
GSM549117patient 073, normal, homogenized [OPG study]9.9413593
GSM549138patient 041, cancer, homogenized [OPG study]10.804697
GSM549141patient 045, cancer, homogenized [OPG study]9.6536492
GSM549130patient 028, cancer, homogenized [OPG study]10.886497
GSM549101patient 111, normal, homogenized [OPG study]9.2939891
GSM549105patient 128, normal, homogenized [OPG study]7.5028877
GSM549106patient 134, normal, homogenized [OPG study]7.4740675
GSM549112patient 048, normal, homogenized [OPG study]8.5512885
GSM549125patient 011, cancer, homogenized [OPG study]11.762499
GSM549127patient 024, cancer, homogenized [OPG study]9.8294294
GSM549135patient 035, cancer, homogenized [OPG study]11.331398